Peter Dolan, the embattled chief of

Bristol-Myers

(BMY) - Get Report

, is the new Dick Grasso, Jim Cramer said Wednesday on

CNBC's

"Stop Trading!" segment.

Cramer said Bristol-Myers shares were bouncing back from Plavix-patent worries until a company spokesman said the board stands behind Dolan. The comment is "crushing the stock," Cramer said. Cramer predicted that Zito's support of Dolan will prove just as fleeting as his comments years ago backing former New York Stock Exchange boss Grasso.

Meanwhile the flap between

Viacom

(VIA) - Get Report

Chairman Sumner Redstone and movie star Tom Cruise "really doesn't help" Viacom's sinking stock, Cramer said. In contrast to onetime sibling

CBS

(CBS) - Get Report

, expectations at Viacom have been too high and any publicity aside from how management is going to improve its numbers only adds to the mess. Viacom stock is "a real yawner, frankly," Cramer said.

Sprint

(S) - Get Report

can't get out of its own way, with recent operational stumbles and executive shuffles hitting the stock. But Cramer urged investors to take a second look, saying the company is so poorly run that it is "starting to remind me of AT&T Wireless." He emphasized that Sprint's high-quality assets are good, and that foreign buyers could be interested. The company "is worth something to someone," Cramer concluded.

Cramer said drug chain

Rite Aid

(RAD) - Get Report

is "a cannonball to five smackers" from the recent $4.70, up off $4.07 in the wake of a bad earnings report last time around. He cited the recession fears that have pushed money out of cyclical stocks like

Caterpillar

(CAT) - Get Report

and into drug stores like Rite Aid and

Walgreen

(WAG)

.

And someone, Cramer said, needs to "crack the whip" at asset manager

Legg Mason

(LM) - Get Report

, which Cramer said has failed to consolidate its big

Citigroup

(C) - Get Report

acquisition. He said he wouldn't worry about fund manager Bill Miller, contending that when people start to worry about a top manager, that's when "they tend to snap back."

At the time of publication, Cramer was long Bristol-Myers.

Jim Cramer is a director and co-founder of TheStreet.com. He contributes daily market commentary for TheStreet.com's sites and serves as an adviser to the company's CEO. Outside contributing columnists for TheStreet.com and RealMoney.com, including Cramer, may, from time to time, write about stocks in which they have a position. In such cases, appropriate disclosure is made. To see his personal portfolio and find out what trades Cramer will make before he makes them, sign up for

Action Alerts PLUS. Listen to Cramer's RealMoney Radio show on your computer; just click

here. Watch Cramer on "Mad Money" at 6 p.m. ET weeknights on CNBC. Click

here to order Cramer's latest book, "Real Money: Sane Investing in an Insane World," click

here to get his second book, "You Got Screwed!" and click

here to order Cramer's autobiography, "Confessions of a Street Addict." While he cannot provide personalized investment advice or recommendations, he invites you to send comments on his column by

clicking here.

TheStreet.com has a revenue-sharing relationship with Traders' Library under which it receives a portion of the revenue from Traders' Library purchases by customers directed there from TheStreet.com.